EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Newly Reported Major Diagnoses and Subsequent Self-Reported Hypertension Treatment Status in Korean Adults Aged 50 Years or Older

Renjie Huang, Miao Huang, Rui Zhang

American Journal of Hypertension · 2026-11-10

DOI: 10.1093/ajh/hpag129 ↗
AbstractBibliografische Angaben

Abstract

Abstract BACKGROUND The association between a newly reported major diagnosis and subsequent self-reported hypertension-treatment status remains uncertain. METHODS We analyzed seven overlapping periods of three visits approximately 2 years apart in the Korean Longitudinal Study of Ageing (2006–2008–2010 through 2018–2020–2022). Eligibility required age ≥50 years, physician-diagnosed hypertension at Visit 1, and reported antihypertensive medication use or hypertension treatment at Visits 1 and 2. Newly reported diabetes, cancer, stroke, heart disease, or chronic lung disease was assessed at Visit 2. The Visit 3 outcome was a report of no current hypertension treatment, including no antihypertensive medication use. Modified-Poisson regression used participant-clustered standard errors. The adjusted absolute risk difference was defined as the standardized probability with a newly reported diagnosis minus that without one. RESULTS Among 13,579 observation periods from 3,581 participants, 932 included a newly reported diagnosis. Adjusted probabilities of no reported treatment were 7.5% with and 8.4% without a newly reported diagnosis. The adjusted risk ratio for not receiving treatment for hypertension, including antihypertensive medication, associated with a newly reported diagnosis was 0.89 (95% confidence interval 0.71–1.13); the adjusted absolute risk difference (newly reported diagnosis minus no newly reported diagnosis) was −0.90 percentage points (95% confidence interval −2.66 to 0.85). CONCLUSIONS A newly reported major diagnosis was not associated with self-reported antihypertensive medication use or hypertension treatment approximately 2 years later.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →